PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
29-Nov-2022 MicrobioSeq Boosts Scientific Research with Gene Expression Analysis CD Genomics
25-Nov-2022 CD Formulation Stresses the Importance of Increased Bioavailability Excipients in Drug Formulation CD Formulation
25-Nov-2022 CD Formulation Launches GalNAc Coupling Modification Services for the Development of Drug Delivery Systems CD Formulation
25-Nov-2022 Alfa Chemistry Shows Expertise in Customized Design and Synthesis of Silazanes Alfa Chemistry
24-Nov-2022 Allero Therapeutics Receives EIC Horizon Grant to Advance Treatment of Celiac Disease Allero Therapeutics
24-Nov-2022 OptiBiotix: Scientific community must double-down on efforts to reduce cardiovascular risk following presentation at US Global Engage Conference OptiBiotix Health Plc
23-Nov-2022 Iktos Partners with Medicines for Malaria Venture in Anti-Malarial Drug Discovery Iktos
23-Nov-2022 HpVac Appoints Joana Vitte, MD, PhD, as Chief Scientific Officer HpVac SA
23-Nov-2022 Clinion Achieves GDPR Compliance, continuing its commitment to data privacy and security Clinion
22-Nov-2022 ImaginAb Executes New License and Supply Agreement for CD8 ImmunoPET Technology with TriSalus Life Sciences ImaginAb
22-Nov-2022 BOC Sciences Continues to Power Up RNA Therapeutics with siRNA Products and Services BOC Sciences
21-Nov-2022 Novozymes Is at the Forefront of Digital R&D, Turning Data Into an Advantage With Benchling R&D Cloud Benchling
21-Nov-2022 CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth Defacto communications
21-Nov-2022 CPHI Frankfurt Report predicts ‘biologics outsourcing to surge in 2023, as China’s innovation engine stalls’ Defacto communications
21-Nov-2022 SHIONOGI, ACTIVE CITIZENSHIP NETWORK AND MEPS ADVOCATE FOR URGENT POLICY IMPLEMENTATION IN EU MEMBER STATES AT EU PARLIAMENT EVENT TO ADDRESS THE GROWING THREAT OF ANTIMICROBIAL RESISTANCE Shionogi
19-Nov-2022 Neoletix and Grand Life Group Agree Licensing Deal For Recombinant FVIII Beijing Neoletix Biological Technology Co., Ltd
18-Nov-2022 BGV co-leads €10 million seed investment in neuroscience company FundaMental Pharma BioGeneration Ventures
18-Nov-2022 FundaMental Pharma launches with EUR 10 million in Seed financing led by BGV and Thuja Capital to advance a First-in-Class neuroprotectant Fundamental Pharma GmbH
17-Nov-2022 atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical Study Investigating Neuroplasticity Biomarkers in Treatment-Resistant Depression Patients Undergoing Ketamine Treatment atai Life Sciences
16-Nov-2022 Synaffix Named ‘Biotech Company of the Year’ at the LSX European Lifestars Awards Synaffix